[Studies on the clinical significance of glycyl-L-leucine dipeptidase in blood platelets].
D000328:Adult; D000367:Age Factors; D007611:Aprotinin / Q000494:pharmacology; D001792:Blood Platelets / Q000201:enzymology*; D001793:Blood Preservation; D002277:Carcinoma / Q000188:drug therapy; D003276:Contraceptives, Oral / Q000494:pharmacology; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D003556:Cystitis / Q000209:etiology; D004150:Dipeptidases / Q000037:antagonists & inhibitors / Q000097:blood*; D005260:Female; D005998:Glycine; D006801:Humans; D007743:Labor, Obstetric; D007930:Leucine; D008297:Male; D008598:Menstruation; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011247:Pregnancy; D012737:Sex Factors; D013696:Temperature; D014511:Uremia / Q000097:blood
D003276:Contraceptives, Oral; D003520:Cyclophosphamide; D007611:Aprotinin; D004150:Dipeptidases; D007930:Leucine; D005998:Glycine
Untersuchungen zur Frage der dklinischen Bedeutung der Glycyl-L-leucine-Dipeptidaseaktivität der Thrombocyten.